|
1
|
Messner B and Bernhard D: Smoking and
cardiovascular disease: Mechanisms of endothelial dysfunction and
early atherogenesis. Arterioscler Thromb Vasc Biol. 34:509–515.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siasos G, Tsigkou V, Kokkou E, Oikonomou
E, Vavuranakis M, Vlachopoulos C, Verveniotis A, Limperi M,
Genimata V, Papavassiliou AG, et al: Smoking and atherosclerosis:
Mechanisms of disease and new therapeutic approaches. Curr Med
Chem. 21:3936–3948. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Libby P, Buring JE, Badimon L, Hansson GK,
Deanfield J, Bittencourt MS, Tokgözoğlu L and Lewis EF:
Atherosclerosis. Nat Rev Dis Primers. 5:562019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Craig WY, Palomaki GE and Haddow JE:
Cigarette smoking and serum lipid and lipoprotein concentrations:
An analysis of published data. BMJ. 298:784–788. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maeda K, Noguchi Y and Fukui T: The
effects of cessation from cigarette smoking on the lipid and
lipoprotein profiles: A meta-analysis. Prev Med. 37:283–290. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Selya AS and Hesse ND: Time to first
cigarette and serum cholesterol levels. Soc Sci Med. 174:213–219.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Latha MS, Vijayammal PL and Kurup PA:
Effect of exposure of rats to cigarette smoke on the metabolism of
lipids. Atherosclerosis. 70:225–231. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lietz M, Berges A, Lebrun S, Meurrens K,
Steffen Y, Stolle K, Schueller J, Boue S, Vuillaume G,
Vanscheeuwijck P, et al: Cigarette-smoke-induced atherogenic lipid
profiles in plasma and vascular tissue of apolipoprotein
E-deficient mice are attenuated by smoking cessation.
Atherosclerosis. 229:86–93. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zong C, Song G, Yao S, Guo S, Yu Y, Yang
N, Guo Z and Qin S: Cigarette smoke exposure impairs reverse
cholesterol transport which can be minimized by treatment of
hydrogen-saturated saline. Lipids Health Dis. 14:1592015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma B, Chen Y, Wang X, Zhang R, Niu S, Ni
L, Di X, Han Q and Liu C: Cigarette smoke exposure impairs lipid
metabolism by decreasing low-density lipoprotein receptor
expression in hepatocytes. Lipids Health Dis. 19:882020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lusis AJ: Atherosclerosis. Nature.
407:233–241. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Poirier S, Mayer G, Poupon V, McPherson
PS, Desjardins R, Ly K, Asselin MC, Day R, Duclos FJ, Witmer M, et
al: Dissection of the endogenous cellular pathways of PCSK9-induced
low density lipoprotein receptor degradation: Evidence for an
intracellular route. J Biol Chem. 284:28856–28864. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Urban D, Pöss J, Böhm M and Laufs U:
Targeting the proprotein convertase subtilisin/kexin type 9 for the
treatment of dyslipidemia and atherosclerosis. J Am Coll Cardiol.
62:1401–1408. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cohen JC, Boerwinkle E, Mosley TH Jr and
Hobbs HH: Sequence variations in PCSK9, low LDL, and protection
against coronary heart disease. N Engl J Med. 354:1264–1272. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kathiresan S; Myocardial Infarction
Genetics C; Myocardial Infarction Genetics Consortium, : A PCSK9
missense variant associated with a reduced risk of early-onset
myocardial infarction. N Engl J Med. 358:2299–2300. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sabatine MS: PCSK9 inhibitors: Clinical
evidence and implementation. Nat Rev Cardiol. 16:155–165. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang ZH, Li TH, Peng J, Zheng J, Li TT,
Liu LS, Jiang ZS and Zheng XL: PCSK9: A novel inflammation
modulator in atherosclerosis? J Cell Physiol. 234:2345–2355. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cipolla-Neto J and Amaral FGD: Melatonin
as a hormone: New physiological and clinical insights. Endocr Rev.
39:990–1028. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mayo JC, Sainz RM, Gonzalez Menendez P,
Cepas V, Tan DX and Reiter RJ: Melatonin and sirtuins: A ‘not-so
unexpected’ relationship. J Pineal Res. 62:e123912017. View Article : Google Scholar
|
|
20
|
Arioz BI, Tastan B, Tarakcioglu E, Tufekci
KU, Olcum M, Ersoy N, Bagriyanik A, Genc K and Genc S: Melatonin
attenuates LPS-induced acute depressive-like behaviors and
microglial NLRP3 inflammasome activation through the SIRT1/Nrf2
pathway. Front Immunol. 10:15112019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hardeland R: Melatonin and inflammation -
Story of a double-edged blade. J Pineal Res. 65:e125252018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shi J, Bai Y, Qiu S, Li Y, Kou C, Tao Y,
Zhen Q, Gu Y, Yu Y, Zhang K, et al: Classified status of smoking
and quitting has different associations with dyslipidemia in
residents in northeast China. Clin Chim Acta. 486:209–213. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Muscat JE, Harris RE, Haley NJ and Wynder
EL: Cigarette smoking and plasma cholesterol. Am Heart J.
121:141–147. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kuzuya M, Ando F, Iguchi A and Shimokata
H: Effect of smoking habit on age-related changes in serum lipids:
A cross-sectional and longitudinal analysis in a large Japanese
cohort. Atherosclerosis. 185:183–190. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Merianos AL, Jandarov RA, Khoury JC and
Mahabee-Gittens EM: Tobacco smoke exposure association with lipid
profiles and adiposity among U.S. adolescents. J Adolesc Health.
62:463–470. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han SG, Howatt DA, Daugherty A and Gairola
CG: Atherogenic and pulmonary responses of ApoE- and LDL
receptor-deficient mice to sidestream cigarette smoke. Toxicology.
299:133–138. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ridker PM: LDL cholesterol: Controversies
and future therapeutic directions. Lancet. 384:607–617. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Seidah NG and Prat A: The proprotein
convertases are potential targets in the treatment of dyslipidemia.
J Mol Med (Berl). 85:685–696. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Seidah NG, Awan Z, Chrétien M and Mbikay
M: PCSK9: A key modulator of cardiovascular health. Circ Res.
114:1022–1036. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Park SW, Moon YA and Horton JD:
Post-transcriptional regulation of low density lipoprotein receptor
protein by proprotein convertase subtilisin/kexin type 9a in mouse
liver. J Biol Chem. 279:50630–50638. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Walley KR, Thain KR, Russell JA, Reilly
MP, Meyer NJ, Ferguson JF, Christie JD, Nakada TA, Fjell CD, Thair
SA, et al: PCSK9 is a critical regulator of the innate immune
response and septic shock outcome. Sci Transl Med. 6:258ra1432014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ding Z, Liu S, Wang X, Deng X, Fan Y,
Shahanawaz J, Shmookler Reis RJ, Varughese KI, Sawamura T and Mehta
JL: Cross-talk between LOX-1 and PCSK9 in vascular tissues.
Cardiovasc Res. 107:556–567. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang X, Bian Y, Zhang R, Liu X, Ni L, Ma
B, Zeng R, Zhao Z, Song X and Liu C: Melatonin alleviates cigarette
smoke-induced endothelial cell pyroptosis through inhibiting
ROS/NLRP3 axis. Biochem Biophys Res Commun. 519:402–408. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ding Z, Liu S, Wang X, Deng X, Fan Y, Sun
C, Wang Y and Mehta JL: Hemodynamic shear stress via ROS modulates
PCSK9 expression in human vascular endothelial and smooth muscle
cells and along the mouse aorta. Antioxid Redox Signal. 22:760–771.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mitchell JP and Carmody RJ: NF-κB and the
transcriptional control of inflammation. Int Rev Cell Mol Biol.
335:41–84. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ahn KS and Aggarwal BB: Transcription
factor NF-kappaB: A sensor for smoke and stress signals. Ann N Y
Acad Sci. 1056:218–233. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ben J, Jiang B, Wang D, Liu Q, Zhang Y, Qi
Y, Tong X, Chen L, Liu X, Zhang Y, et al: Major vault protein
suppresses obesity and atherosclerosis through inhibiting IKK-NF-κB
signaling mediated inflammation. Nat Commun. 10:18012019.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu Y, Wang F, Fan L, Zhang W, Wang T, Du Y
and Bai X: Baicalin alleviates atherosclerosis by relieving
oxidative stress and inflammatory responses via inactivating the
NF-κB and p38 MAPK signaling pathways. Biomed Pharmacother.
97:1673–1679. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang Z, Liu B, Zhu J, Wang D and Wang Y:
Nicotine-mediated autophagy of vascular smooth muscle cell
accelerates atherosclerosis via nAChRs/ROS/NF-κB signaling pathway.
Atherosclerosis. 284:1–10. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu S, Deng X, Zhang P, Wang X, Fan Y,
Zhou S, Mu S, Mehta JL and Ding Z: Blood flow patterns regulate
PCSK9 secretion via MyD88-mediated pro-inflammatory cytokines.
Cardiovasc Res. 116:1721–1732. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Morgan MJ and Liu ZG: Crosstalk of
reactive oxygen species and NF-κB signaling. Cell Res. 21:103–115.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Loloei S, Sepidarkish M, Heydarian A,
Tahvilian N, Khazdouz M, Heshmati J and Pouraram H: The effect of
melatonin supplementation on lipid profile and anthropometric
indices: A systematic review and meta-analysis of clinical trials.
Diabetes Metab Syndr. 13:1901–1910. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Agil A, Navarro-Alarcón M, Ruiz R,
Abuhamadah S, El-Mir MY and Vázquez GF: Beneficial effects of
melatonin on obesity and lipid profile in young Zucker diabetic
fatty rats. J Pineal Res. 50:207–212. 2011.PubMed/NCBI
|
|
45
|
Hussain SA: Effect of melatonin on
cholesterol absorption in rats. J Pineal Res. 42:267–271. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hoyos M, Guerrero JM, Perez-Cano R, Olivan
J, Fabiani F, Garcia-Pergañeda A and Osuna C: Serum cholesterol and
lipid peroxidation are decreased by melatonin in diet-induced
hypercholesterolemic rats. J Pineal Res. 28:150–155. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yin J, Li Y, Han H, Chen S, Gao J, Liu G,
Wu X, Deng J, Yu Q, Huang X, et al: Melatonin reprogramming of gut
microbiota improves lipid dysmetabolism in high-fat diet-fed mice.
J Pineal Res. 65:e125242018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kauppinen A, Suuronen T, Ojala J,
Kaarniranta K and Salminen A: Antagonistic crosstalk between NF-κB
and SIRT1 in the regulation of inflammation and metabolic
disorders. Cell Signal. 25:1939–1948. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xu F, Xu J, Xiong X and Deng Y:
Salidroside inhibits MAPK, NF-κB, and STAT3 pathways in
psoriasis-associated oxidative stress via SIRT1 activation. Redox
Rep. 24:70–74. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Singh CK, Chhabra G, Ndiaye MA,
Garcia-Peterson LM, Mack NJ and Ahmad N: The role of sirtuins in
antioxidant and redox signaling. Antioxid Redox Signal. 28:643–661.
2018. View Article : Google Scholar : PubMed/NCBI
|
